|
May 7
|
VALNEVA Declaration of shares and voting rights: April 30, 2025
|
|
May 7
|
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
|
|
May 7
|
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
|
|
Mar 10
|
High Growth Tech Stocks In Europe For March 2025
|
|
Feb 18
|
Valneva hits 2024 sales target but plans lower cash burn in 2025
|
|
Feb 18
|
Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook
|
|
Feb 17
|
Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens
|
|
Jan 3
|
VALNEVA Declaration of shares and voting rights: December 31, 2024
|